can glp-1 cause kidney stones Glucagon-like Peptide-1 Receptor Agonists and Diabetic Disease: From Bench to Bed-Side GLP-1 agonists in the treatment
Description
JAMA 334 , 12551266 (2025)
Refrigerate upon arrival
The exploration of GLP-1s mechanisms also present opportunities for novel therapeutic developments
It is administered once daily
Efficacy and safety of tirzepatide in patients with type 2 diabetes: a systematic review and meta-analysis
Sales in 2023 were up 3.8% and rose 4% in 2024 and 5.1% in 2025
